A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: A retrospective experience Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Neoadjuvant Therapy
  • Urinary Bladder Neoplasms

abstract

  • Neoadjuvant GC is feasible and allows for timely drug delivery. The proportion of GC-treated patients whose primary tumors were downstaged, with prolonged disease-free survival and minimal or no residual disease, was similar to MVAC-treated patients.

publication date

  • November 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2585515

Digital Object Identifier (DOI)

  • 10.1002/cncr.23848

PubMed ID

  • 18823036

Additional Document Info

start page

  • 2471

end page

  • 7

volume

  • 113

number

  • 9